Felodipine Tablet, Extended Release — FDA Drug Shortage

To Be Discontinued — Par Health, USA LLC

The FDA lists a drug shortage record for Felodipine Tablet, Extended Release (tablet) from Par Health, USA LLC with status To Be Discontinued. The shortage was first posted on Oct 7, 2026.

Shortage details

Status
To Be Discontinued
Company
Par Health, USA LLC
Package NDC
0603-3581-28
Dosage Form
Tablet
Presentation
Felodipine, Tablet, Extended Release, 2.5 mg (NDC 0603-3581-28)
Initial Posting
Oct 7, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.